Ultragenyx Pharma

Forecast & Rating20 analysts currently cover Ultragenyx Pharma, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $26.79, about 75.1% upside from the current price of $15.30. Price targets range from $16.00 to $39.00 — a wide spread, showing clear disagreement over just how much Ultragenyx Pharma can rise. Historically, about 2.4% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Ultragenyx Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Oct 8, 2026; for reference only and not investment advice.